Federal Register / Vol. 71, No. 240 / Thursday, December 14, 2006 / Notices 75255 

Evaluation of Selenium in Elk in the 

Southeast Idaho Phosphate Resource 

Area 

Illinois 

Belvidere Municipal Landfill #1 

Bohn Heat Transfer Facility 

Dixie Auto Salvage 

Lincoln Limited Landfill 

Smith-Douglass 

Iowa 

Iowa City Former Manufactured Gas 

Plant Site 

Tails A Waggin’ Pet Resort—Arsenic 

Soil Contamination 

Kentucky 

Martin County Coal Slurry Release 

Rubbertown Industrial Area 

Louisiana 

Bayou Sorrel—Post-Hurricane 

Groundwater Sampling Evaluation 

Combustion, Inc.—Post-Hurricane 

Groundwater Sampling Evaluation 

Devil’s Swamp Lake—A Review of Fish 

Data 

Hurricane Response Sampling 

Assessment for D.L. Mud, Inc. 

Hurricane Response Sampling 

Assessment for Gulf Coast Vacuum 

Services 

Hurricane Response Sampling 

Assessment for PAB Oil & Chemical 

Service, Inc. 

Hurricane Response Sampling 

Assessment for the Agriculture Street 

Landfill 

Hurricane Response Sampling 

Assessment for the Southern 

Shipbuilding Corporation 

Petro Processors of Louisiana, Inc.—

Post-Hurricane Groundwater 

Sampling Evaluation 

Maine 

Contaminant Accumulation Potential 

in Plants and Animals Used by the 

Aroostook Band of Micmac Indians at 

the Former Loring Air Force Base 

Holtrachem Manufacturing Company 

Massachusetts 

Environmental Data Review for 

Witchcraft Heights Elementary School 

and Nearby Properties 

Former Zonolite Facility—Wemelco 

Way 

Michigan 

I–75/Caniff Area (Hamtramck) Lead 

Contamination (a/k/a ‘‘Grand Haven’’

Area (Hamtramck) Lead 

Contamination) 

Little Black Creek Sediments 

Little Black Creek Sediments—

Floodplain Soil Sampling Results 

Petersburg Mercury Site 

Minnesota 

Former Park Rapids Dump 

Off-Site Soils: CMC Heartland Partners 

Lite Yard Site 

St. Louis River Sediments: U.S. Steel 

Site—Dioxin and Polycyclic Aromatic 

Hydrocarbon Chemical Signatures 

(Fingerprints) in Sediments 

St. Louis River Sediments: U.S. Steel 

Site—Technical Review of 

Discrepancies in 2002 Lacer Induced 

Fluorescence Data, and 2003 and 2004 

Analytical Data 

Missouri 

Brewer Brothers Petroleum Bulk Plant 

Former Cardwell Memorial Hospital 

Former Zonolite Company/W.R. Grace 

Facility—St. Louis 

Sherrill Mini Mart/Health Clinic 

Nevada 

Yerington Anaconda Mine Site (a/k/a 

Anaconda Mine) 

New Hampshire 

Bear Brook Villa 

Cancer Incidence: Residents of 

Claremont, Sullivan County, New 

Hampshire (Wheelabrator-Claremont 

Site) 

New Jersey 

Adrow Chemical Company Site 

Kiddie Kollege—Mercury Exposure 

Investigation 

Matteo & Sons (a/k/a Matteo Iron and 

Metal Site) 

New York 

Mariners Marsh Park—Area of Concern 

North Carolina 

Payne Road Solvents 

Sigmon’s Septic Tank Service—

Evaluation of Surface Water Data 

Ohio 

Fair Oak Park 

Oregon 

North Morrow and Northwest Umatilla 

Perchlorate Area 

Salem-Keizer School District—3M 

Flooring 

Pennsylvania 

Former W.R. Grace/Zonolite Co. 

Facility—Investigation of Nearby Play 

Area 

Waymart Spill Site 

Tennessee 

Clover Creek Workers (a/k/a Velsicol 

Chemical Corp.) 

Cypress Creek Sub-Area III 

Glover Site (a/k/a Tennessee Products) 

Skyline Drive Dump 

Texas 

Cox Road Dump Site—Barium Health 

Concern 

Tenaha Wood Treating 

Tronox LLC, Texarkana Facility 

Washington 

BSB Diversified/Hexcel Corporation—

Evaluation of Ground Water 

Contamination 

DNR Triangle Gravel Pit 

Gilbert Elementary School—Evaluation 

of Soil Contamination 

Holmes Harbor 

Lincoln Elementary School—Evaluation 

of Soil Contamination 

Manson Elementary School—Evaluation 

of Soil Contamination 

Naches Valley Intermediate School—

Evaluation of Soil Contamination 

Robertson Elementary School—

Evaluation of Soil Contamination 

Washington Elementary School—

Evaluation of Soil Contamination 

Wisconsin 

Badger Army Ammunition Plant—

Dinitrotoluene in Private Wells 

Econocare Cleaners Vapor Intrusion 

Investigation 

Redi-Quik Dry Cleaners—Vapor 

Intrusion in a Private Residence 

Dated: December 8, 2006. 

Kenneth Rose, 

Acting Director, Office of Policy, Planning, 

and Evaluation, National Center for 

Environmental Health/Agency for Toxic 

Substances and Disease Registry. 

[FR Doc. E6–21263 Filed 12–13–06; 8:45 am] 

BILLING CODE 4163–70–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30 Day–07–0641] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

The Centers for Disease Control and 

Prevention (CDC) publishes a list of 

information collection requests under 

review by the Office of Management and 

Budget (OMB) in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

Chapter 35). To request a copy of these 

requests, call the CDC Reports Clearance 

Officer at 404–639–4604 or send a 

e-mail to omb@cdc.gov. Send written 

comments to CDC Desk Officer, Office of 

Management and Budget, Washington, 

DC or by fax to (202) 395–6974. Written 

comments should be received within 30 

days of this notice. 


rwilkins on PROD1PC63 with NOTICES
75256 Federal Register / Vol. 71, No. 240 / Thursday, December 14, 2006 / Notices 

Background and Brief Description 

Descriptive Epidemiology of Missed 

or Delayed Diagnoses for Conditions 

Detected by Newborn Screening—(OMB 

No. 0920–0641)—Revision—National 

Center for Environmental Health 

(NCEH), Centers for Disease Control and 

Prevention (CDC). Every state in the 

United States and Washington, DC, has 

a public health program to test newborn 

babies for congenital metabolic and 

other disorders through laboratory 

testing of dried blood spots. These 

programs screen for between four and 

36 different conditions including 

phenylketonuria (PKU) and congenital 

hypothroidism, with testing performed 

in both state laboratories and private 

laboratories contracted by state health 

departments. The screening process or 

system is broader than the state public 

health newborn screening program, 

which is composed only of the 

laboratory and follow-up personnel. 

Most children born with metabolic 

disease are identified in a timely 

manner and within the parameters 

defined by the newborn screening 

system of each state. These children are 

referred for diagnosis and treatment. 

However, some cases are not detected at 

all or the detection comes too late to 

prevent harm. These ‘‘missed cases’’

often result in severe morbidity such as 

mental retardation or death. 

In this project, we will continue to 

collect information about missed or 

delayed diagnoses in order to update 

and expand a previous epidemiological 

study of missed cases of two disorders 

published in 1986. We will assess the 

number of cases of each disorder 

missed, and the potential reasons for the 

miss and legal outcomes. Data will be 

collected by asking state public health 

laboratory directors, newborn screening 

laboratory managers, follow-up 

coordinators, specialists at metabolic 

clinics, and parent groups with an 

interest in newborn screening for 

information regarding missed cases. An 

estimated 135 remaining respondents 

will participate in our study by 

completing one or two short 

questionnaires that ask for information 

regarding the details of any missed or 

delayed cases of which they are aware. 

The survey will highlight procedures 

and actions taken by states and other 

participants in newborn screening 

systems to identify causes of missed 

cases and to modify policies and 

procedures to prevent or minimize 

recurrences. The information gleaned 

from this study may be used to help 

craft changes in the screening protocols 

that will make the process more 

organized and efficient and less likely to 

fail an affected child. 

Respondent burden is approximately 

3 minutes for the State Form and 10 

minutes for the Case Report Form. There 

are no costs to the respondents other 

than their time. The total estimated 

annual burden hours are 28. 

ESTIMATED ANNUALIZED BURDEN HOURS

Respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden 

(hours) 

per response 

Total 

burden 

(hours) 

Director, State Newborn Screening 

Laboratory.

State Form .......................................... 25 1 3/60 1 .3 

Case Report Form .............................. 25 1 10/60 4 .2 

Follow-up State Coordinator ............... State Form .......................................... 25 1 3/60 1 .3 

Case Report Form .............................. 25 1 10/60 4 .2 

Metabolic Clinic Employee ................. State Form .......................................... 60 1 3/60 3 

Case Report Form .............................. 60 1 10/60 10 

Parent Advocate ................................. Case Report Form .............................. 5 1 10/60 0 .8 

Parent ................................................. Case Report Form .............................. 20 1 10/60 3 .3 

Dated: December 8, 2006. 

Joan F. Karr, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 06–9723 Filed 12–13–06; 8:45 am] 

BILLING CODE 4163–18–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day-07–05AJ] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–639–5960 and 

send comments to Seleda Perryman, 

CDC Assistant Reports Clearance 

Officer, 1600 Clifton Road, MS–D74, 

Atlanta, GA 30333 or send an e-mail to 

omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

National Surveillance for Severe 

Adverse Events Associated with 

Treatment of Latent Tuberculosis 

Infection—New—Division of 

Tuberculosis Elimination (DTBE), 

National Center for HIV, STD, and TB 

Prevention (NCHSTP), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

As part of the national TB elimination 

strategy, the American Thoracic Society 

and CDC have published 

recommendations for targeted testing for 

TB and treatment for latent TB infection 

(LTBI). However, between October 2000 

and September 2004, the CDC received 

reports of 50 patients with severe 

adverse events associated with the use 

of the two or three-month regimen of 

rifampin and pyrazinamide (RZ) for the 

treatment of LTBI; 12 (24%) patients 


rwilkins on PROD1PC63 with NOTICES